NASDAQ · Biotechnology

Alps Group Inc (ALPS) Stock

$0.47 -0.26% NASDAQ: ALPS Healthcare

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions.

Valuation

MetricValue
Price$0.47
Market Cap$77.38M
P/E Ratio-0.03
P/B Ratio-0.15
P/S Ratio23.01
EPS (TTM)$-0.41
52-Week High$2.90
52-Week Low$0.45
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE922.42%
ROA-680.00%
ROCE931.64%
Gross Margin-2233.33%
Operating Margin-2233.33%
Net Margin-20.05%
Debt/Equity-0.53
Current Ratio0.44

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$4.0M$2.0M$3.0M$3.0M
Operating Profit$0$-1.0M$-2.0M$-2.0M$-67.0M
Net Profit$0$-1.0M$-2.0M$-3.0M$-68.0M
EPS$0.00$0.00$-0.38$-0.68$-14.64
Op Margin—-14.9%-98.0%-73.6%-1983.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$118.0M$119.0M$7.0M$7.0M$10.0M
Total Liabilities$4.0M$5.0M$5.0M$8.0M$10.0M
Cash$1.0M$0$0$0$3.0M
Borrowings$0$0$1.0M$1.0M$3.0M

Latest News

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia GlobeNewswire · Jun 23, 2026 Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022 GlobeNewswire · Jun 9, 2026 Alps Group Gets Nasdaq Non-Compliance Notice MT Newswires · May 19, 2026 Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency GlobeNewswire · May 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$-2.0M—
Investing Cash Flow$-117.0M$-1.0M$-2.0M$-1.0M—
Financing Cash Flow$0$1.0M$1.0M$2.0M—
Net Cash Flow$1.0M$0$0$2.0M—
Free Cash Flow$0$0$-2.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.25
FCF Yield0.00%
Quick Ratio0.33
Interest Coverage-136.91
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Institutional HolderSharesReport Date
Millennium Management Llc387,4952026-03-31
MMCAP International, Inc. SPC54,0002026-03-31
Jones Financial Companies, L.L.L.P.24,9502026-03-31
SkyView Investment Advisors, LLC10,0002026-03-31
Saba Capital Management, L.P.14,0542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARGYFAvanti Helium Corp. $0.35 +5.64% -28.82 $44.88M 0.00%
BNRG $0.56 -0.27% -0.01 $286856 0.00%
CHKRChesapeake Granite Wash Trust $0.34 +0.66% 4.46 $16.12M 17.65%
EDBL $2.59 -11.00% -0.05 $314778 0.00%
GIPRGeneration Income Properties, Inc. $0.68 +4.16% -0.04 $373538 0.00%

About Alps Group Inc

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Alps Group Inc is led by CEO Seng Kong Tham, employs 2 people, headquartered in MY, publicly traded since 2025.

Alps Group Inc (ALPS) stock trades at $0.47 with a market capitalization of $77.38M. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of -0.15, price-to-sales of 23.01. Over the past 52 weeks the stock has ranged between $0.45 and $2.90, and currently trades 83.8% below its 52-week high.

On profitability, Alps Group Inc generates a return on equity (ROE) of 922.42% — well above the market average, a sign of a high-quality business, return on capital employed of 931.64%, an operating margin of -2233.33%, a net profit margin of -20.05%.

Official website: alps-holdings.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides